Intracavernous injection of papaverine (ICIP) J. BuvatA. LemaireM. Buvat-Herbaut OriginalPaper Pages: 150 - 155
Clinical experience with vasoactive intracavernous pharmacotherapy for treatment of impotence A. A. SidiK. -K. Chen OriginalPaper Pages: 156 - 159
Intracavernosal pharmacotherapy: the pharmacologic erection program H. Padma-NathanI. GoldsteinR. J. Krane OriginalPaper Pages: 160 - 165
Late results on the treatment of neurogenic impotence by self-intracavernous-injection (SICI) of vasoactive drugs R. ViragH. SussmanK. Shoukry OriginalPaper Pages: 166 - 170
Intracavernosal injection of vasoactive intestinal polypeptide (VIP) does not induce erection in man per se G. WagnerT. Gerstenberg OriginalPaper Pages: 171 - 172
New methods in the diagnosis of impotence: RigiScan® penile tumescence and rigidity monitoring and diagnostic papaverine hydrochloride injection A. A. G. M. GiesbersJ. L. BruinsU. Jonas OriginalPaper Pages: 173 - 176
The intracavernous application of alpha-adrenergic drugs in the treatment of priapism T. BlockW. SturmE. Schmiedt OriginalPaper Pages: 178 - 181
Improved results with intracavernous vasoactive drug infusion following new surgical techniques for vasculogenic impotence E. AustoniC. BellorofonteF. Mantovani OriginalPaper Pages: 182 - 189
Non-stomal continent reservoir: use of detubularized ileal segment for bladder replacement P. K. Reddy Free Paper Pages: 190 - 193
Diagnosis and management of patients with posterior hypospadias J. EberleU. SchweikertG. Bartsch Free Paper Pages: 194 - 200